Hangzhou DAC Biotech Co., Ltd

DAC Biotech is a pioneering company in the research, development, production, and commercialization of Antibody-Drug Conjugates (ADC) drugs. Founded by a team of high-level entrepreneurs in collaboration with Zhejiang pharmaceutical companies and investment agencies, DAC Biotech operates in the biotechnology and pharmaceutical sectors. The core technical team comprises five Ph.D. holders, along with masters, bachelors, and specialists in technology development, technical advice, and result transfer. The company focuses on creating advanced medical solutions through cutting-edge biotechnology and medical technology. DAC Biotech serves pharmaceutical companies, healthcare providers, and research institutions, offering innovative ADC drugs that target specific diseases with high precision. The business model revolves around the development and commercialization of these specialized drugs, generating revenue through partnerships, licensing agreements, and direct sales.

Keywords: ADC drugs, biotechnology, pharmaceutical, research, development, commercialization, medical technology, drug intermediates, technical advice, innovation.